PE20160748A1 - FORMATION OF SEMIPERMEABLE POROUS ARTIFICIAL CRUST - Google Patents
FORMATION OF SEMIPERMEABLE POROUS ARTIFICIAL CRUSTInfo
- Publication number
- PE20160748A1 PE20160748A1 PE2015000904A PE2015000904A PE20160748A1 PE 20160748 A1 PE20160748 A1 PE 20160748A1 PE 2015000904 A PE2015000904 A PE 2015000904A PE 2015000904 A PE2015000904 A PE 2015000904A PE 20160748 A1 PE20160748 A1 PE 20160748A1
- Authority
- PE
- Peru
- Prior art keywords
- formation
- porous artificial
- crust
- semipermeable porous
- artificial crust
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0085—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
- A61L2300/222—Steroids, e.g. corticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/43—Hormones, e.g. dexamethasone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/442—Colorants, dyes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Prostheses (AREA)
Abstract
Referida a una composicion farmaceutica que comprende: a) 1% a 5% de azosulfamida, b) 0,004% a 0,007% de violeta de genciana, c) 0,001% a 0,003% de dexametasona, d) 0,5% a 2% de pantenol y e) 0,03% a 0,06% de gentamicina, la cual es util en el tratamiento de heridas, superficies danadas, quemaduras de tipo A-AB, entre otras, mediante la formacion de una costra en la superficie danadaReferring to a pharmaceutical composition comprising: a) 1% to 5% of azosulfamide, b) 0.004% to 0.007% of gentian violet, c) 0.001% to 0.003% of dexamethasone, d) 0.5% to 2% of panthenol and e) 0.03% to 0.06% of gentamicin, which is useful in the treatment of wounds, damaged surfaces, A-AB type burns, among others, through the formation of a crust on the damaged surface
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP120105043A AR089518A1 (en) | 2012-12-27 | 2012-12-27 | SEMIPERMEABLE PORTABLE ARTIFICIAL COSTRA |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20160748A1 true PE20160748A1 (en) | 2016-08-21 |
Family
ID=49959135
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2015000904A PE20160748A1 (en) | 2012-12-27 | 2013-11-04 | FORMATION OF SEMIPERMEABLE POROUS ARTIFICIAL CRUST |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20160000963A1 (en) |
| EP (1) | EP2939678B1 (en) |
| JP (1) | JP6073500B2 (en) |
| CN (1) | CN105073121B (en) |
| AR (1) | AR089518A1 (en) |
| AU (1) | AU2013368699B2 (en) |
| CA (1) | CA2896488C (en) |
| ES (1) | ES2633970T3 (en) |
| IL (1) | IL239618B (en) |
| MX (1) | MX2015007747A (en) |
| PE (1) | PE20160748A1 (en) |
| RU (1) | RU2015128753A (en) |
| UY (1) | UY35111A (en) |
| WO (1) | WO2014104898A2 (en) |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2364563A (en) * | 1941-09-25 | 1944-12-05 | John B Stribling | Keratitic medicament |
| US3146162A (en) * | 1961-05-05 | 1964-08-25 | Harold A Abramson | Gentian violet adsorption complex |
| US3238100A (en) * | 1963-07-23 | 1966-03-01 | American Maize Prod Co | Starch phosphate film composition and method of dressing wounds with same |
| US3328259A (en) * | 1964-01-08 | 1967-06-27 | Parachem Corp | Dressing for a wound containing a hemostatic agent and method of treating a wound |
| US3577516A (en) * | 1969-12-02 | 1971-05-04 | Nat Patent Dev Corp | Preparation of spray on bandage |
| US3969498A (en) * | 1973-09-13 | 1976-07-13 | University Of The Pacific | Dressing and method for treating a wound |
| JP3261807B2 (en) * | 1992-06-09 | 2002-03-04 | 味の素株式会社 | Gel composition having thixotropy |
| US20040018241A1 (en) * | 1997-09-26 | 2004-01-29 | Noven Pharmaceuticals, Inc. | Bioadhesive compositions and methods for topical administration of active agents |
| FR2819721B1 (en) * | 2001-01-19 | 2005-02-04 | L M D | TREATMENT OF ESCARTS WITH NON-METABOLIZABLE SUGAR AND POLYMERIC ABSORBER |
| US20050031540A1 (en) * | 2001-11-20 | 2005-02-10 | Nielsen Per Julius | Visco dye |
| US20030203032A1 (en) * | 2002-04-25 | 2003-10-30 | Schultz Clyde L. | Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease |
| AU2003290517A1 (en) * | 2002-08-20 | 2004-04-19 | General Wound Kare, Inc. (A Corporation Of Deleware) | Medical pad, and method for making and using |
| DE10357046A1 (en) * | 2003-12-04 | 2005-06-30 | Beiersdorf Ag | Cosmetic or dermatological preparations containing a combination of green dye and anti-inflammatory agent |
| CN1293883C (en) * | 2004-05-21 | 2007-01-10 | 邹宏 | Wipe-off and recovery treatment lotion and preparation method thereof |
| US20070161936A1 (en) * | 2006-01-06 | 2007-07-12 | Svetlik Harvey E | Wound treatment-dressing and method of manufacture |
| ES2304103B1 (en) * | 2007-02-22 | 2009-08-07 | Biocosmetics S.L. | COMPOSITION FOR TREATMENT OF XEROSTOMY OR DRY MOUTH. |
| EP2588096A4 (en) * | 2010-07-02 | 2013-12-25 | Holden Brien Vision Inst | Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease |
| CN101947226A (en) * | 2010-09-10 | 2011-01-19 | 李晓倩 | Drops for treating pink eye |
-
2012
- 2012-12-27 AR ARP120105043A patent/AR089518A1/en active IP Right Grant
-
2013
- 2013-11-01 UY UY0001035111A patent/UY35111A/en not_active Application Discontinuation
- 2013-11-04 AU AU2013368699A patent/AU2013368699B2/en not_active Ceased
- 2013-11-04 WO PCT/PE2013/000010 patent/WO2014104898A2/en active Application Filing
- 2013-11-04 PE PE2015000904A patent/PE20160748A1/en not_active Application Discontinuation
- 2013-11-04 MX MX2015007747A patent/MX2015007747A/en unknown
- 2013-11-04 RU RU2015128753A patent/RU2015128753A/en not_active Application Discontinuation
- 2013-11-04 US US14/655,677 patent/US20160000963A1/en not_active Abandoned
- 2013-11-04 ES ES13867652.3T patent/ES2633970T3/en active Active
- 2013-11-04 JP JP2015550354A patent/JP6073500B2/en not_active Expired - Fee Related
- 2013-11-04 CN CN201380068529.0A patent/CN105073121B/en not_active Expired - Fee Related
- 2013-11-04 EP EP13867652.3A patent/EP2939678B1/en not_active Not-in-force
- 2013-11-04 CA CA2896488A patent/CA2896488C/en not_active Expired - Fee Related
-
2015
- 2015-06-24 IL IL239618A patent/IL239618B/en active IP Right Grant
-
2018
- 2018-08-29 US US16/115,874 patent/US20190022274A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL239618A0 (en) | 2015-08-31 |
| CA2896488A1 (en) | 2014-07-03 |
| EP2939678B1 (en) | 2017-04-19 |
| CA2896488C (en) | 2017-11-21 |
| AU2013368699A1 (en) | 2015-07-16 |
| AR089518A1 (en) | 2014-08-27 |
| JP2016504357A (en) | 2016-02-12 |
| JP6073500B2 (en) | 2017-02-01 |
| CN105073121B (en) | 2018-12-04 |
| UY35111A (en) | 2013-12-31 |
| EP2939678A4 (en) | 2016-06-08 |
| AU2013368699B2 (en) | 2017-08-10 |
| US20160000963A1 (en) | 2016-01-07 |
| MX2015007747A (en) | 2015-09-04 |
| CN105073121A (en) | 2015-11-18 |
| ES2633970T3 (en) | 2017-09-26 |
| WO2014104898A3 (en) | 2015-01-08 |
| US20190022274A1 (en) | 2019-01-24 |
| EP2939678A2 (en) | 2015-11-04 |
| RU2015128753A (en) | 2017-02-01 |
| IL239618B (en) | 2018-01-31 |
| WO2014104898A2 (en) | 2014-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2015003442A1 (en) | Heterocyclic derivatives | |
| CL2016001547A1 (en) | Compositions for oral care | |
| CL2015002941A1 (en) | Therapeutic uses of empaglifozin | |
| EA201591430A1 (en) | COMPOUNDS AND THEIR APPLICATIONS FOR MODULATION OF HEMOGLOBIN | |
| EA201591426A1 (en) | COMPOUNDS AND THEIR APPLICATIONS FOR MODULATION OF HEMOGLOBIN | |
| CL2016002971A1 (en) | Combination. | |
| CL2011000170A1 (en) | Solid and stabilized pharmaceutical composition comprising a pharmaceutically active ingredient, titanium oxide and a plasticizer; procedure to stabilize the pharmaceutical composition during a light irradiation. | |
| EA201591432A1 (en) | COMPOUNDS AND THEIR APPLICATIONS FOR MODULATION OF HEMOGLOBIN | |
| MX2015016983A (en) | Nuclear transport modulators and uses thereof. | |
| CL2015002835A1 (en) | New pyridine derivatives | |
| ECSP11011076A (en) | TREATMENT OF COGNITIVE DISORDERS WITH (R) -7-CHLORINE-N- (QUINUCLIDIN-3-IL) BENZO [B] THIOPHEN-2-CARBOXAMIDE AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME | |
| EA201200484A1 (en) | PHARMACEUTICAL COMPOSITION WITH EXISTING SUBSTANCES - METHORMIN AND SYTAGLIPTIN OR VILDAGLIPTIN | |
| CO2017006898A2 (en) | Insulin glargine / lixisenatide fixed ratio formulation | |
| PE20160012A1 (en) | TREATMENT OF MYOPATHIC AND NEUROGENERATIVE DISEASES BY PROTEIN ADMINISTRATION BY PARENTERAL ADMINISTRATION | |
| AR111374A1 (en) | USE OF LIK066 IN PATIENTS WITH HEART FAILURE | |
| CL2012003341A1 (en) | Pharmaceutical composition for oral administration comprising bendamustine or an ester, a salt or a solvate thereof, and an excipient which is a non-ionic and hydrophilic surfactant; pharmaceutical combination; and its use for the treatment of chronic lymphocytic leukemia and multiple myeloma, among other diseases. | |
| CL2009001841A1 (en) | Use of a sustained release composition of 4-aminopyridine to prepare a medicament useful for treating multiple sclerosis in a subject. | |
| DOP2010000327A (en) | USE OF DRONEDARONA TO PREPARE A MEDICINAL PRODUCT FOR THE TREATMENT OF PATIENTS WITH ARRITMIA AND THAT HAVE A CREATININE LEVEL INCREASE DUE TO THE ADMINISTRATION OF DRONEDARONA | |
| AR099680A1 (en) | IMPROVED MUTEINS OF COAGULATION FACTOR VIII | |
| AR094224A1 (en) | PHARMACEUTICAL COMPOSITION IN THE FORM OF AN ORAL SUSPENSION | |
| CO7151515A2 (en) | Methods to treat gait and / or balance deficiency in patients with multiple sclerosis using an aminopyridine | |
| PE20160748A1 (en) | FORMATION OF SEMIPERMEABLE POROUS ARTIFICIAL CRUST | |
| RS53033B (en) | Combinations of vildagliptin and glimepiride | |
| CR20140526A (en) | DRONEDARONE FOR USE IN LEISHMANIOSIS, FORMULATIONS AND ASSOCIATIONS FOR USE IN LEISHMANIOSIS | |
| EA201891848A1 (en) | PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF FIBROSIS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AE | Restoration of lapsed or forfeited application | ||
| FD | Application declared void or lapsed |